Who is sponsoring NCT05801315?

NCT05801315 is sponsored by University of Siena.

What drugs are being tested in NCT05801315?

Interventions in NCT05801315: Glycine powder air polishing, Full mouth ultrasonic debridement.

What condition does NCT05801315 study?

NCT05801315 studies Peri-implant Mucositis.

Is NCT05801315 still recruiting?

NCT05801315 is currently completed. Last updated 27 July 2023.

Last reviewed 2023-07-27 · How we verify

NCT05801315

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Non-surgical Treatment of Peri-implant Mucositis: FMUD vs FMUD and Air-Flow Master Piezon®

Completed NA Last updated 27 July 2023

What this trial tests

NA trial testing Glycine powder air polishing in Peri-implant Mucositis in 52 participants. Completed in 20 March 2023.

Timeline

1 March 2020

Primary endpoint
20 March 2023

20 March 2023

Quick facts

Lead sponsor	University of Siena
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	52
Start date	1 March 2020
Primary completion	20 March 2023
Estimated completion	20 March 2023
Sites	1 location across Italy

Drugs / interventions tested

Glycine powder air polishing
Full mouth ultrasonic debridement

Conditions studied

Peri-implant Mucositis — all drugs for Peri-implant Mucositis →

Sponsor

University of Siena

Who can join

Adults 18 to 70, any sex, with Peri-implant Mucositis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the present study is to evaluate the adjunctive effect of glycine-powder air-polishing (GPAP) to full-mouth ultrasonic debridement (Fm-UD) in the treatment of peri-implant mucositis, and to determine the predictive role of implant and patient-level variables for disease resolution. Both treatments are described in the literature, but few studies are available on their comparison.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Treatment of peri-implant mucositis: Adjunctive effect of glycine powder air polishing to professional mechanical biofilm removal. 12 months randomized clinical study.
Nicola D, Isabella R, Carolina C, Baldini N, et al · · 2024 · cited 5× · PMID 38317375 · DOI 10.1111/cid.13304

Verify or expand the search:

Other recruiting trials for Peri-implant Mucositis

Currently open trials in the same condition.

NCT07349095 — AI-Assisted Colorimetric Diagnosis of Peri-Implant Mucosal Erythema · NA · recruiting
NCT07140146 — Trehalose vs Glycine Air-Polishing in Peri-Implant Mucositis Treatment · NA · recruiting
NCT06645444 — Immediate Implant Placement With Different Materials of Customized Healing Abutment for Guiding Peri-implant Soft Tissue · NA · recruiting
NCT07047261 — Efficacy of a Xanthan-based Chlorhexidine Gel in the Treatment of Peri-implant Mucositis · NA · recruiting
NCT06364982 — Distance Between Dental Implants as a Risk Indicator for Peri-implant Disease. · recruiting

Other University of Siena trials

Trials by the same sponsor.

NCT07053865 — Electromyographic Assessment of Sleep Bruxism in Patients With Stage III and IV Periodontitis · completed
NCT07053878 — Changes in Bruxism Activity After Periodontal Treatment in Patients With Periodontitis · NA · completed
NCT07018284 — Postoperative Pain Evaluation After Obturation With Different Sealers · NA · recruiting
NCT07019298 — Success of Endodontic Treatment With Different Obturation Techniques and Sealer Cements · NA · recruiting
NCT06923748 — Comparison of Two Interdental Devices for Peri-Implant Plaque Control · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05801315 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Siena
Last refreshed: 27 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05801315.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing